These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26680360)

  • 1. A Novel Anti-Inflammatory Effect for High Density Lipoprotein.
    Cameron SJ; Morrell CN; Bao C; Swaim AF; Rodriguez A; Lowenstein CJ
    PLoS One; 2015; 10(12):e0144372. PubMed ID: 26680360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein and apolipoprotein A-I inhibit palmitate-induced translocation of toll-like receptor 4 into lipid rafts and inflammatory cytokines in 3T3-L1 adipocytes.
    Yamada H; Umemoto T; Kawano M; Kawakami M; Kakei M; Momomura SI; Ishikawa SE; Hara K
    Biochem Biophys Res Commun; 2017 Mar; 484(2):403-408. PubMed ID: 28137586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide triggers Weibel-Palade body exocytosis.
    Bhatia R; Matsushita K; Yamakuchi M; Morrell CN; Cao W; Lowenstein CJ
    Circ Res; 2004 Aug; 95(3):319-24. PubMed ID: 15217913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation.
    Murphy AJ; Woollard KJ; Suhartoyo A; Stirzaker RA; Shaw J; Sviridov D; Chin-Dusting JP
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1333-41. PubMed ID: 21474825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
    Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
    Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
    Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA
    Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I enhances proliferation of human endothelial progenitor cells and promotes angiogenesis through the cell surface ATP synthase.
    González-Pecchi V; Valdés S; Pons V; Honorato P; Martinez LO; Lamperti L; Aguayo C; Radojkovic C
    Microvasc Res; 2015 Mar; 98():9-15. PubMed ID: 25445031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.
    Matsushita K; Morrell CN; Lowenstein CJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11483-7. PubMed ID: 15273282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein: a potent inhibitor of inflammation.
    Murphy AJ; Woollard KJ
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):710-8. PubMed ID: 19930423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
    Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
    Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of niacin.
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells.
    Norata GD; Marchesi P; Pirillo A; Uboldi P; Chiesa G; Maina V; Garlanda C; Mantovani A; Catapano AL
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):925-31. PubMed ID: 18218986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I.
    Seetharam D; Mineo C; Gormley AK; Gibson LL; Vongpatanasin W; Chambliss KL; Hahner LD; Cummings ML; Kitchens RL; Marcel YL; Rader DJ; Shaul PW
    Circ Res; 2006 Jan; 98(1):63-72. PubMed ID: 16339487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone activates endothelial exocytosis.
    Jeong Y; Chaupin DF; Matsushita K; Yamakuchi M; Cameron SJ; Morrell CN; Lowenstein CJ
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3782-7. PubMed ID: 19223584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.